News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Courtagen Life Sciences, Inc. to Partner with Tetracore Inc. in Biodefense Initiative


2/9/2012 6:54:44 AM

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc. (“Courtagen”), a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, today announced that it has entered into a strategic collaboration with Tetracore, Inc. (“Tetracore”) to develop a next generation biothreat assay for identifying and diagnosing high priority biological agents in clinical and environmental samples. Some of the target agents include those which cause significant diseases such as anthrax and plague, as well as dangerous toxins such as ricin and botulinum. The combined effort will focus on addressing the critical need to quickly and accurately identify the pathogen while also quantifying the magnitude of the potential threat.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES